Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.
about
Quantum dot-based multiplexed imaging in malignant ascites: a new model for malignant ascites classification.The rationale for HPV-related oropharyngeal cancer de-escalation treatment strategiesTumor infiltrating lymphocytes (TILs) before and after neoadjuvant chemoradiotherapy and its clinical utility for rectal cancer.mTOR and MEK1/2 inhibition differentially modulate tumor growth and the immune microenvironment in syngeneic models of oral cavity cancer.Trial Watch-Small molecules targeting the immunological tumor microenvironment for cancer therapy.Clinical significance of the preoperative platelet count and platelet-to-lymphocyte ratio (PLT-PLR) in patients with surgically resected non-small cell lung cancer.Differences in T-cell infiltrates and survival between HPV+ and HPV- oropharyngeal squamous cell carcinoma.Kv1.3 Channels Mark Functionally Competent CD8+ Tumor-Infiltrating Lymphocytes in Head and Neck Cancer.Identification of an atypical etiological head and neck squamous carcinoma subtype featuring the CpG island methylator phenotypeIrradiation enhances dendritic cell potential antitumor activity by inducing tumor cell expressing TNF-α.Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer.An adaptive immune response driven by mature, antigen-experienced T and B cells within the microenvironment of oral squamous cell carcinoma.Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: a meta-analysis.Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer.Two immune-enhanced molecular subtypes differ in inflammation, checkpoint signaling and outcome of advanced head and neck squamous cell carcinoma.A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment.Checkpoint immunotherapy in head and neck cancers.
P2860
Q35168709-614F711D-3914-41C0-9A71-C68845A02C1FQ35838231-84360F52-E459-4463-9327-568D178C3A19Q35929864-0351B07D-633E-4EF8-9BF3-AD5B5E1C04A2Q36546669-A022FB55-A010-45EB-B846-B231969679F4Q37079141-1710A521-B0C7-4B26-8ECD-B345E15CFE8CQ37392676-D3A2F49D-0B5F-4140-998A-F1E2405F2FEAQ37474503-F4890038-052C-45DC-A366-5A620EE09490Q37559965-F2FE917F-E00C-4FDD-BF9D-D32E9F407037Q37714302-6B3A3F0F-3945-4B3D-AA2D-C4BB3E900C66Q38716570-6B987F05-E849-4392-87D6-38C8EE200F7FQ38935248-61AE2892-C124-4E6F-850E-A6CBD613AF29Q40056727-091C0CCF-8A49-44BA-B18B-1E06D58912C4Q41554887-F299B700-88EE-4C2C-966F-6066EF8FA90BQ45226424-9955FD26-3FF3-4EFA-9215-B0188B13179FQ50545401-A369A0B2-0612-4203-824C-3E4A257CE4B0Q52716939-BBEB86E5-6E0B-4E61-9FCA-C6D312AC0B66Q53098427-37481B77-2B69-4D72-BC51-171C8AD4BBFE
P2860
Tumor-infiltrating lymphocytes favor the response to chemoradiotherapy of head and neck cancer.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Tumor-infiltrating lymphocytes ...... erapy of head and neck cancer.
@en
type
label
Tumor-infiltrating lymphocytes ...... erapy of head and neck cancer.
@en
prefLabel
Tumor-infiltrating lymphocytes ...... erapy of head and neck cancer.
@en
P2093
P2860
P356
P1433
P1476
Tumor-infiltrating lymphocytes ...... erapy of head and neck cancer.
@en
P2093
Christian Weiss
Emmanouil Fokas
Franz Rödel
Panagiotis Balermpas
P2860
P304
P356
10.4161/ONCI.27403
P50
P577
2014-01-01T00:00:00Z